Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-064096)

Filing Details

Accession Number:: 0001181431-10-064096
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-29 19:30:39
Reporting Period:: 2010-12-27

Filing Date:: 2010-12-29
Accepted Time:: 2010-12-29 19:30:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1128495	Anadys Pharmaceuticals Inc	ANDS	Pharmaceutical Preparations (2834)	223193172

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1290165	Qvt Fund Lp	Walkers Spv, Walkers House 87 Mary Street George Town, Grand Cayman E9 KY1-9005		No	No	Yes	No
1290166	Qvt Associates Gp Llc	1177 Avenue Of The Americas 9Th Floor New York NY 10036		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2010-12-27	1,714,210	$1.30	10,524,441	No	4	P	Indirect	Through QVT Fund LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value	Acquisiton	2010-12-28	12,200	$1.34	10,536,641	No	4	P	Indirect	Through QVT Fund LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value	Acquisiton	2010-12-28	532,490	$1.44	11,069,131	No	4	P	Indirect	Through QVT Fund LP and Quintessence Fund L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Through QVT Fund LP and Quintessence Fund L.P.
No	4	P	Indirect	Through QVT Fund LP and Quintessence Fund L.P.
No	4	P	Indirect	Through QVT Fund LP and Quintessence Fund L.P.